MABp1: 'Clever' New Antibody Targeting Colorectal Cancer

A trial using MABp1, an antibody targeting interleukin 1 alpha, showed some benefit for patients with advanced colorectal cancer, but Dr Kerr thinks the clinical endpoint used was a ' little soft. '

Source: Medscape Pathology and Laboratory Medicine Podcast - February 14, 2018 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts